Details for 2012758652
Up to date per 01.04.2026
Actions
Details for 2012758652
Deleted
European Patent
16.07.2014 A
24.10.2018 B1
30.08.2011
US
201161528931 P
30.08.2011
NL
2007319
A23L 33/135 20160101AFI20180430BHEP
Owner
Caelus Pharmaceuticals B.V.50, Rondweg 3474 KG ZegveldNL
Academisch Medisch CentrumMeibergdreef 9 1105 AZ AmsterdamNL
Representative
No representatives present
Inventor
NIEUWDORP, Max112-L Weesperzijde NL-1091 EN AmsterdamNL
DE VOS, Willem Meindert77 Oude Bennekomseweg NL-6717 LM EdeNL